Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products CurtissWright Corp CW Poised for Strategic Advantage Amid Geopolitical Uncertainty Smart Glasses Sales Surge Amid Privacy Debates Meta Leads Growth Timex Group Indias Revenue Triples to INR 800 Crore Flags FY26 as Pivotal Growth Milestone Musical Theatre Stars Success Strategies Offer Lessons for Entertainment Investors Ferrari Unveils 550000 Electric SUV Amid Design Criticism and Share Decline Antero Resources Q1 2026 Earnings Slight EPS Miss Amid Strong Natural Gas Operations TSS Q1 2026 Earnings EPS Blows Past Estimates Surprise of 17027 FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged NVNO Q3 2025 Earnings Narrower Net Loss Surpasses Analyst Expectations Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline MSC Q4 2025 Earnings 011 EPS No Revenue Disclosure Stock Declines Banco De Chile ADS Holds Steady Near 3878 as Key Levels Remain in Focus Netskope Inc NTSK Gains 147 as Shares Hold Near Resistance Zone Viemed Healthcare VMD Rises 281 Approaching Key Resistance Level MGR Preferred Shares Edge Lower Testing Key Support Levels Amid Yield Environment PEO Stock Slides 095 Testing Key Support Levels Amid Natural Resources Uncertainty Oil Prices Reverse Course as Geopolitical Tensions Continue to Drive Market Volatility COFS Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Consensus Macerich MAC Nears Resistance After Modest Gains Supported by Real Estate Sector Momentum APEI Q1 2026 Earnings EPS Surges Past Estimates with 383 Beat TOWN Q1 2026 Earnings EPS Misses Estimates by Nearly 5 Stock Edges Lower CHEF Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Stock Pullback Honeywell Q1 2026 Earnings EPS Beats Estimates by 439 Shares Edge Higher Warrior Met Coal HCC Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds EIKN Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Intensifies Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances